Jabril Bensedrine
US Liaison, International Business Development at Globallians
Jabril Bensedrine
US Liaison, International Business Development at Globallians
New York, New York
Overview
Work Experience
US Liaison, International Business Development
2022 - Current
An invitation-only association of International Business Experts: 🌐17 active member companies specialized in international business development 👥 450 multicultural team members working locally 🗺 73 countries 🏢 27 offices located all around the world ⏳ 25 years of country and multisectoral expertise 📊 1 200 projects manager each year 📊 9 000 clients successfully supported internationally Worldwide Areas of Expertise: ✅ Strategy and market research ✅ Distribution and supply chain ✅ Business development ✅ Purchasing and quality ✅ M&A / Industrial Investment ✅ Subsidiary and business centres ✅ HR / Hiring ✅ Agency representation
Industry Associate Professor, Technology Management & Innovation
2009
Within the Tandon School of Engineering of New York University, teaching Innovation, Entrepreneurship, Information Systems, and the Capstone course. Coaching teams on projects in collaboration with a broad range of partners ranging from technology ventures to engineering firms, governmental organizations, and global Fortune 500 corporations.
Managing Director
2008
Technology business development for 120+ companies up to 7 years in a row: user-need assessment; strategy; go-to-market plan; partnerships; representation and distribution. Sectors: hardware (industrial equipment, sensors, IOT, lasers, infrared); software (AI, AR, cloud-native ERP); healthcare; scientific instruments. More at www.trianagroup.com. Products and technologies we represent are used by thousands of world-class organizations, including but not limited to Airbus, Amazon, Bosch, Chanel, Coca-Cola, Dupont, Ford, GSK, L'Oreal, Medtronic, Mercedes, Nestle, P&G, Rolls Royce, Sanofi, Toyota, 3M and more. Examples of current roles include serving as an advisor to Plastec Ventilation, Inc. (broad business development advisory role since the company's acquisition by SEAT Ventilation. Among the world leaders in fume extraction systems for corrosive and explosive environments such as laboratories, healthcare, and chemical plants.)
Advisor
2018
Disruptive Technologists is a STEM nonprofit with a mission to educate, inspire, and empower a diverse community of tech disrupters pursuing cutting-edge innovation, through Microsoft and NYU Tandon School of Engineering hosted live events, which are relayed online thanks to Ziotag's support. Its activities also include Think Tank talks, newsletters, networking, and other programs that speak to disruptive innovation over a range of markets and industries. “Even as someone working at a top tech company, I myself have learned and gained very interesting insights from the panel discussions and think tank dinners. As New York and surrounding communities aspire to invest deeper in technology, a resource like Disruptive Technologists is a phenomenal asset to continue inspiring the next generation.” (Rachel Loui, Head of Business & Industrial Markets, Google)
Accredited Expert
2018
Stratexio's Accredited Experts facilitate the international expansion of 100+ companies totaling $1.7 Billion annual revenue by coaching their CEOs. Results: 74% international revenue growth in 3 years. CEOs work with Stratexio to plan rational and sustainable expansion strategies.
Strategy & Marketing Faculty at U. of Paris-Est, ESSEC, Mountbatten (Oxford U.), Pace U.
1998 - 2008
Over the years and different dates, taught Strategic Management courses as Faculty and Adjunct Faculty, starting at the University of Paris-East Marne-la-Vallee (UMLV), then Essec, then for the Oxford University-affiliated Mountbatten Institute, San Francisco State University, U. of Phoenix, Pace U., and many more. I was also a member of the ELM Research & Strategy consulting group, which provided PhD-level research and feasibility studies to organizations such as the University of California at Berkeley and the City of San Francisco (for which we explored the feasibility of a pioneering health insurance project which was a trailblazer toward universal healthcare.)
Consultant
2002 - 2004
Supported investment projects totaling $700+ million from start-ups to multi-billion-dollar companies, helping them validate sales projections and develop their business cases. Examples include: -For an $18 billion American company: visited troubling $60M foreign supplier and provided diligence leading to a take-over by related investment fund. -For a high-net worth investor: performed on-site business development due diligence of start-up company following a $1 million investment. -For an $8 million electronic components company with 100%+ annual growth: identified, screened and signed new sales agents nationwide, and initiated partnership options with electronic design and engineering firm. -For a midmarket company seeking international expansion: benchmarked and short-listed foreign competitors & acquisition target, leading to joint-venture partnership. Other examples available upon request.
Post-Doc at the Haas School of Business
1998 - 2002
Performed numerous speaking engagements, workshops, and conference presentations across Europe and the US. Published several articles and book chapters including with Oxford University Press, Edward Elgar, and John Wiley & Sons. Initiated, raised funding for, and organized international conferences including at INSEAD in Paris and U.C. Berkeley.
Industry Analyst, Eurostaf, a subsidiary of Group Les Echos - Financial Times
1992 - 2002
Contributed to and authored market intelligence studies and industry analysis reports on new trends in healthcare and retail used by Fortune 500 corporations and the investment community, including prominent clients ranging from Airbus to Bayer, from Coca Cola to BMW, and hundreds more. Examples of reports include. - Pharmaceutical corporations marketing & population aging - Sustainability innovative business models & competitive positioning strategies in US retail - Large European retail networks & innovations - European OTC market & trends - Scenarios on the global pharmaceutical market & trends - Prospects for current pharmaceutical leaders & global trends - Global hospital market for pharmaceuticals - Series of "Groups Analysis" Deep-Dive notes (chemical and pharmaceutical industries) - The European parapharmaceutical market trends - Retailtainment business model analysis, competitive benchmarking and emerging trends